Pestalozzi advises H.C. Wainwright in connection with private placement in NLS Pharmaceutics Ltd

Pestalozzi advises H.C. Wainwright in connection with private placement in NLS Pharmaceutics Ltd

25.03.2024

Pestalozzi advised H.C. Wainwright LLC in connection with a direct offering of 7,000,000 common shares in NLS Pharmaceutics Ltd., a Swiss clinical-stage biopharmaceutical company listed at NASDAQ (Ticker: NLSP/NLSPW) and in a private placement warrants to purchase up to 3'500'000 common shares. H.C. Wainwright & Co., LLC acted as exclusive placement agent for the offering.

Pestalozzi advised H.C. Wainwright & Co. LLC as to all matters of Swiss law.

Contact